Stable reconstitution of vascular endothelial beds upon transplantation of progenitor cells represents an important challenge due to the paucity and generally limited integration/expansion potential of most identified vascular related cell subsets. We previously showed that mouse fetal liver (FL) hemato/vascular cells from day 12 of gestation (E12), expressing the Stem Cell Leukaemia (SCL) gene enhancer transgene (SCL-PLAP 1 cells), had robust endothelial engraftment potential when transferred to the blood stream of newborns or adult conditioned recipients, compared to the scarce vascular contribution of adult bone marrow cells. However, the specific SCL-PLAP 1 hematopoietic or endothelial cell subset responsible for the long-term reconstituting endothelial cell (LTR-EC) activity and its confinement to FL developmental stages remained unknown. Using a busulfan-treated newborn transplantation model, we show that LTR-EC activity is restricted to the SCL-PLAP 1 VE-cadherin 
INTRODUCTION
Transplantation of vascular progenitor cells with potential to engraft and long-term contribute to functional endothelial vascular beds in multiple organs has been proposed as an important strategy for genetic correction of vascular diseases, inducing vascular regeneration and as a tool for manipulation of vascular mediated organ homeostasis and growth [1] [2] [3] 
CXCR4
1 cell populations in the mouse [4] [5] [6] [7] [8] [9] , promoted postnatal physiological and pathological neovascularization in different organs, including the liver [10] [11] [12] , heart [13, 14] , and kidney [15] [16] [17] [18] . This has led to clinical trials of circulating/BM cell subsets for therapy of certain human vascular disorders [19] . Apparently, infused cells participated in the recovery of injured vasculature through the production of paracrine factors that promote endogenous endothelial cell (EC) growth and/or by direct incorporation/differentiation into organ endothelial tubular structures. While paracrine neoangiogenic effects seem to be a BM-derived cell-mediated common mechanism involved in short term vascular injury recovery [6, [20] [21] [22] , the long term incorporation potential of BM-derived cell populations into organ vascular endothelium is considered highly variable, depending on the injured model, targeted organ or specific characteristics of the donor cell population [8, 23] . Therefore, the search for cell sources with substantial vascular endothelial potential and functional organ integration capacity upon transplantation remains an important area of research to be explored.
Distinct subsets of postnatal primary microvascular ECs, able to stably reconstitute organ vascular beds upon transfer to injured tissue [24, 25] and in particular liver sinusoidal endothelial cells (LSECs), have been described. LSECs transferred to adult animals can efficiently integrate into and reconstitute the liver sinusoidal endothelium of acutely injured or regenerating livers [26] [27] [28] , modulate liver regeneration [27, 29] , fibrosis [30, 31] , and alleviate coagulation defects [32] . Despite the fact that transfer of LSECs constitute one of the most promising cell-based strategies for restoration of vascular damage and organ homeostasis [33, 34] , they display reduced plasticity when compared to circulating/BMderived endothelial progenitor cells (EPCs) and long term survival of the LSEC-derived grafts is only observed in the liver [26] , a factor that potentially restraints their use in applications involving systemic vascular pathologies.
Using intravenous cell transfer into myelo-ablated newborn-mice, we found that cells from the FL, a predominant hematopoietic organ at this stage, had a much superior contribution potential to the endothelium of different organs than postnatal BM cells [35] . Newborns present an active organ growth and neovascularization activity, thereby it was proposed that this might facilitate the engraftment of transferred EC/EPCs in different locations [35, 36] . The FL multiorgan EC engraftment potential is hence referred as long-term reconstituting EC (LTR-EC) activity, involving cell homing/lodging, differentiation to organ-associated endothelial types and long term stabilization of the donor-derived vascular beds. In the current study, we determine the hematopoietic and endothelial reconstitution potential of different E12 FL SCL-PLAP 1 cell subsets, characterized by the activation of the hematopoietic stem cell/endothelial SCL-3 0 Enhancer, derived from the stem cell leukaemia (SCL) gene, a key transcription factor for the normal development of hematopoietic progenitors and blood vessels [37] [38] [39] [40] . We isolate and characterize a novel progenitor population that is strongly committed to the endothelial lineage, likely responsible for the LTR-EC activity at different stages of FL development but functionally absent in the adult liver. Furthermore, productive integration of the grafted vasculature is supported by its association to proliferating hepatocyte-like foci together with participation in the general circulation. To our knowledge, the here described FL cell population represents a so far not recognized largely committed EC/EPC cell subset endowed with long-term and multiorgan vascular reconstituting potential.
MATERIALS AND METHODS

Mice
Animals were maintained in the CABD animal care facility and procedures performed under the guidance of the European Community Legislation with the approval of ethical committee of CSIC and Universidad Pablo de Olavide. Transgenic lines for transplantation assays include the SCL3 0 Enh-hPLAP mice, expressing the human placental alkaline phosphatase (PLAP) reporter gene [35, 39] , the SCL-3 0 Enh-Lacz mice expressing the b-galactosidase reporter gene [41] and the actin-DsRed mice expressing the DsRed-MST reporter gene under the actin regulatory elements (Jackson Laboratories, stock 005441) [42] .
Cell Preparation
To obtain fetal tissues, timed breeding of heterozygous/homozygous SCL-3 0 Enh-PLAP transgenic mice was established. Fetuses were obtained from day 10 (E10) to day 14 (E14) of gestation. Cell preparation procedures from embryonic/fetal and adult hematopoietic tissues were previously published [35, 43] , (Supporting Information). A fragment of yolk sac (YS) was used for embryo typing by staining with the PLAP substrate, nitroblue tetrazolium (NBT) (Roche, Mannheim, Germany, www.lifescience.roche.com) as described [39] . LSEC enriched nonparenchymal cell (NPC) fraction was obtained from adult mouse livers by a two-step collagenase perfusion technique and gradient percoll centrifugation as described [26, 29] with modifications (Supporting Information).
Flow Cytometry Analysis and Cell Sorting
Cell suspensions were stained, analyzed and separated by flow cytometry as previously described [35] (Sup. Information). A FACSAria flow cytometer equipped with two lasers and run with a FACSDiva software (BD Biosciences, www. bdbiosciences.com/eu) was used.
Newborn Transplantation Assay and Chimerism Analysis
Transplantation assays were performed transferring cells to the facial vein of wild type busulfan treated newborn mice as described in detail [35, 44, 45] (Supporting Information). Longterm hematopoietic and vascular reconstitution analysis was performed at 3-8 months post-transplant. Mice were anesthetized, blood collected from the heart and perfused with 50 ml Trisbuffered saline containing 0.001% heparin. Hematopoietic organs were homogenized in phosphate buffered saline (PBS) supplemented with 5% of foetal calf serum (FCS) (PBS 5%FCS). The liver, heart, kidney and lung were fixed in zinc solution (BD-Pharmingen, San Diego, CA, www.bdbioscience.com). For studies related to immuno-histological detection of proliferative markers and DsRed reporter gene, mice were perfused with PBS and the liver fixed in 4% formaldehyde solutions (Merck KGaA, Germany). Perfusion was not performed on <4-weeks-old mice and when livers were weighed. 
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Hematopoietic engraftment was assessed by PCR for PLAP and LacZ reporter genes on genomic DNA from peripheral blood and hematopoietic organs and by FACS for PLAP and CD45 expression in peripheral blood [35] . Mice were considered reconstituted when circulating SCL-PLAP 1 cells represented at least 1%. Levels of hematopoietic chimerism were also determined by semi-quantitative PCR for PLAP and LacZ on genomic DNA from hematopoietic organs as published [35, 43] (Supporting Information). In some experiments, the DsRed marker was used for multilineage hematopoietic contribution. Vascular engraftment was assessed by systematic histological screening for SCL-PLAP 1 donor-derived sinusoidal vascularlike clusters (v.c.) on liver sections by NBT staining [35] (Supporitng Information). For quantification of vascular engraftment on NBT stained liver sections we determined the frequency of mice positive for v.c. and the relative tissue area containing v.c., denominated vascular cluster area (v.c.a.), using the Image AnalySIS software program V3.1.110, as detailed in Supporting Information Figure 1C and Supporting Information. Heart, kidney, and lung sections from selected mice were also screened by NBT staining and scored as indicated in Supporting Information Table 1 . Triple immunostaining for PLAP, CD45 and Isolectin B4 (IsoB4) or CD31 was performed to confirm the endothelial nature of the v.c. as described [17, 35] . Costaining for Ki67, P-H3 and albumin was assessed on 4% formaldehyde fixed liver sections from some 3 weeks old mice. Detection of DsRed fluorescence and PLAP immunostaining was performed on cryosections. For expanded immune-histological reagents, antibodies, and methods refer to Supporting Information.
OP9 Endothelial Cord/Colony Forming Assay
OP9 stromal cell line, expressing GFP, was provided by J.C. Zuñiga-Pflucker [46] . Cells were cocultured in 96-well plates containing subconfluent OP9 cells in MEMa containing 10% FCS, 1% P/S, 5310
25 M 2b2mercaptoethanol (Sigma-Aldrich, Steinheim, Germany, www.sigmaaldrich.com) and 50 ng/ml VEGF (Cell Signaling Technology, www.cellsignal.com) [47, 48] . After 4 days, cells from duplicated wells were fixed in Methanol/DMSO 5% and stained for CD31 as described with modifications [47] (Supporting Information). Sequential images covering the area of each well were generated and single CD31 1 cords and colonies counted. Images were obtained with a Leica DMIRB inverted microscope including a Leica DFC350FX digital camera (www.leica-microsystems.com).
Hematopoietic CFU-C Assay
Clonogenic Colony Forming Unit in Culture (CFU-C) for erythroid/myeloid progenitor assay was performed as described [40] . In brief, FL sorted cells were transferred to 1.5 ml of cytokine-supplemented methylcellulose medium (M3434, StemCell Technologies, www.stemcell.com) and plated in duplicates in 6-well plates. Hematopoietic colonies were scored after 7 days under a Leica MZ7.5 stereoscope including a Nikon DS5 digital camera and DSL1 control unit (http:// www.nikon.es/es_ES/).
B Lymphoid Culture Assay
OP9 B lymphoid differentiation/expansion assay was performed as described [49, 50] Table 2 ). Similar to long-term transplanted primary leukemia cells that incorporated into the liver vascular endothelium as CD45 1 endothelial-like cells [56] , this result suggested that rare hematopoietic committed cells were able to preserve hematopoietic features upon endothelial integration. Nevertheless, we cannot exclude the possibility that FL SCL-PLAP 1 VEcad 1
CD45
1 cells may contribute to CD45 2 ECs in other models of acute vascular damage, including retinal ischemia or aggressive lung tumor models, as shown for transplanted adult BM-derived HSCs/progeny or myeloid progenitors [7, 8] .
We next analyzed the long-term endothelial contribution in hearts and kidneys from selected chimeric mice, (Supporting Information Table 1 ). Endothelial vascular clusters in the heart were only observed in mice transferred with SCL-PLAP 1 VE-cad 1 (2 out of 6 mice presenting liver sinusoidal v.c.) (Supporting Information Fig. 1E ) and SCL-PLAP
2 cells (3 out of 9 analyzed mice, 2 of them presenting liver sinusoidal v.c.), (Fig. 2) . Detection of donor cells in the kidneys was highly variable in mice presenting hematopoietic chimerism (SCL-PLAP (Fig. 3D) . The presence of other pan-endothelial related markers Table 1 for individual values). Data was obtained from 3 to 6 independent transplantation experiments for each population. Abbreviations: ee, embryo equivalent; PLAP, placental alkaline phosphatase reporter gene. 1 EC cords/colonies were produced by 500 P 1 V 1 C -cells and extensive EC network by 2,000 cells (not shown). The number of scored wells was as follows:
, n 5 5; P 
LTR-EC Activity is Largely Ascribed to Fetal Liver Developmental Stages
We next asked if LTR-EC activity was restricted to the FL during development. The mouse embryonic liver develops at around stage E8 and ECs forming the microvasculature are first observed by stage E9-E10, concomitant with the appearance of hematopoietic cells [62, 63] . SCL-PLAP 1 VE-
cells were detected by E10 (Fig. 4A) 
CD45
2 cells may acquire LTR-EC activity as a maturational process along development, analogous to the maturational events driving the changes in the reconstitution potential of immature HSC to acquire HSC properties [50, 63] . Indeed, at E10 a greater proportion of VEcad 1
2 cells were negative for Lyve1 (Fig. 4B) , a marker proposed to be associated to maturation of liver endothelial cells during development [58] .
We next analyzed the presence of LTR-EC activity in the adult liver. Endothelial engraftment potential of adult LSECs, has been shown by transferring purified CD31
1 LSECs or a LSEC enriched NPCs fraction (LSEC-NPC) into preconditioned adult mice [26, 29, 32] . Flow cytometry analysis indicated that 4 6 2.6% of LSEC-NPC cells were SCL-PLAP 1 VEcad low1 CD45
2 (Fig. 4A) , most expressing the endothelial markers Lyve1 and CD31 (Fig. 4B) . Despite the presence of an incremented percentage of ECs compared to E12 FL cells, less 
VE-cad
1 CD45 2 cells are detected during development and in adult liver (blue gate). Cell suspensions from pooled E10-E12 FL and from individual E14 FL and adult livers were analyzed. E10, n 5 4; E11, n 5 6; E12, n 5 13; E14, n 5 12; adults, n 5 4. (B): VE-cad 1 CD45 2 profile for Lyve1 and CD31 endothelial markers expression. Most VE-cad 1 CD45 2 express CD31 while the Lyve1 levels increment with development. Overlaid gray line histograms correspond to unstained controls on VE-cad 1 CD45 2 gated cells. E10, n 5 3; E11, n 5 6; E12, n 5 6; E14, n 5 8; adults, n 5 3. Percentages 6SD of positive cells are shown. 7AAD
1 dead cells were gated out from the analysis window and they represented 12 6 4% in FL E10, 8 6 5% in FL E11, 11 6 5% in FL E12, 5 6 2% in E14 FL and 68 6 17% in adult liver LSEC-NPC fraction. Embryonic/fetal tissues were obtained from at least 3 independent litters for each stage. (C): The number of CD31
1 EC cords/colonies from 500 plated unfractionated and sorted cell populations from E12 FL and adult liver LSEC-NPC fraction is shown (representative sorting windows shown in B). Incremented EC activity is observed from total (TFL) and sorted VEcad
FL cells compared to adult liver-derived counterpart populations. Very low EC activity is identified in FL VEcad (52 6 14 colonies) . The number of scored wells was as follows:
, n 5 9; adult liver LSEC-NPC, n 5 5; adult liver V 1 C 2 L 1 , n 5 6. Two to six independent experiments, including simultaneous cultures for FL and adult liver cells, were performed. (D): Images from NBT staining on liver sections from E11 FL chimera, showing part of a large PLAP 1 vascular-like cluster, and an adult liver chimera, transplanted with LSEC-NPC cells, showing PLAP 1 sporadic sinusoidal-like cells. Number of adult liver chimeras analyzed, n 5 6; sporadic sinusoidal-like cells were observed in two animals. E11 FL chimeras, n 5 6, large vascular clusters observed in all chimeras (see Table 2 and Supporting Information Table 4 ). Scale bars 100 lm. Abbreviations: LSECs, liver sinusoidal endothelial cells; NPC, nonparenchymal cell; PLAP, placental alkaline phosphatase reporter gene; SCL, stem cell leukaemia gene. (Fig. 4D , Table 2 ). This result shows that adult liver LSEC-NPCs cells lack an inherent potential to reconstitute the liver microvasculature when transferred i.v. to Buconditioned newborns.
To further determine if LTR-EC activity was detected in other locations presenting hematopoietic activity in E12 embryos, we performed flow cytometry analysis and transplantation assays with cells obtained from the yolk sac (YS) Figure 5 . Fig. 4A, 4B ) [57] , vascular grafts were rare in AGM and absent from YS chimeras ( Table  2 , Supporting Information Fig. 4C , Supporting Information Table 3 ). These results suggest that the FL is the principal source of SCL-PLAP 1 VE-cad 1 CD45
2
, Lyve1 1 cells with LTR-EC potential.
Analysis of FL Derived Vascular Endothelial Clusters Integration in the Liver of Young Mice. Implications for Vascular Graft Functionality
Functional integration of donor-derived endothelium is a prerequisite for the recovery/modulation of the targeted organ. Functional endothelium should provide and respond to signals necessary for organ formation/regeneration, regulating tissue growth and cell proliferation. Coordinated growth of endothelium and tissue cell has been shown during liver organogenesis [64] , regeneration [29] , and damage recovery [65] . To analyze functionality of the v.c. and whether v.c. associated with cell proliferation during neonatal liver growth we first determined the emergence and expansion of SCL-PLAP 1 v.c.
Mice were transplanted with 10 6 E12 FL cells and the frequency of vascular chimerism and vascular cluster areas (v.c.a.) assessed at different times post-transplant. For these experiments we used unfractionated FL cells, as in these conditions the frequency of vascular chimeras was highly incremented compared with sorted populations (Tables 1 and 2 ). 23 cm 2 ) suggesting that vascular grafts have a limited expansion capability. During this period the liver presented a 1.7-fold weight increment from 1 to 2 weeks old mice (0.16 6 0.02 g to 0.28 6 0.05 g) followed by a 3.2-fold augmentation between 2 and 4 weeks (0,9 6 0.04 g). Liver mass incremented at lower rates from 4 to 8 weeks (1.4 6 0.1 g, 1.5-fold weight increase) and from 8 to 30 weeks (1.9 6 0.2 g, 1.5-fold weight increase) (Fig. 5B) . Thus, robust organ growth is observed between 2-4 weeks, coincidental with v.c. expansion, and consequently proliferation activity is expected to occur.
To determine whether v.c. associated with cell proliferation activity within the 2-4 age interval, livers were analyzed at a post-transplantation time when v.c. are first detected and active liver growth occurs (3 weeks), and at later times when graft expansion stabilizes, liver growth slows down and minimal proliferation is expected (12 weeks). Thick liver sections were stained for BrdU/PLAP and 3D images analyzed using confocal microscopy. Proliferating BrdU 1 cells were evident at 3 weeks and all SCL-PLAP 1 v.c. (n 5 10) included BrdU 1 cells (Fig. 5C ). The majority of these cells appeared to be hepatocyte-like cells. Moreover, the frequency of BrdU 1 nuclei within the tissue area containing the v.c. was significantly higher (3.7 6 1% BrdU 1 nuclei) than in tissue areas without grafts (1.3 6 0.2% BrdU 1 nuclei), indicating a direct association of grafted cells and proliferating cell foci (Fig. 5D) . At 12 weeks post-transplantation no BrdU 1 cells were observed within the v.c. (n 5 10), indicating the absence of continuing proliferation in the grafted region. Based on these observations, we propose that the preferential association of expanding v.c. with proliferating hepatocyte-like cells reflects functional integration of donor-derived endothelium, reminiscent of sinusoidal liver endothelial cell activity that mediate proliferation during regenerative growth [29] . At the moment we cannot distinguish if at 3 weeks post-transplantation, expanding donor-endothelium induces the proliferation of neighboring cells, or whether donor-cells home into proliferative areas containing high levels of VEGF necessary for EC expansion. Indeed, both possibilities are not mutually exclusive.
Analysis of chimeras generated by transplantation with ubiquitously labeled SCL-PLAP; act-DsRed FL cells did not result in DsRed 1 hepatocyte clusters (Supporting Information   Fig. 5 ). This finding is consistent with previous results [35] and . 6 ). It remains to be elucidated if mechanisms coordinating neonatal vascular graft/liver growth are similar to mechanisms acting during adult liver regeneration and whether endothelial expansion predominantly occurs through elongation/remodeling of the cell cytoplasm [67] or through proliferation identified by different markers [68] .
Functionally grafted vasculature has to connect with the host vascular conduits to integrate into the transport network. The detection of administered fluorescent perfusant or the presence of circulatory cells within donor-derived vasculature has been used to demonstrate functionality of vascular grafts [8, 24] . 3D confocal image analysis from v.c. showed that circulating cells were present within the lumen of PLAP 1 vessels at 3 weeks post-transplant (circulating blood cells identified in vessels from 7 out of 10 v.c analyzed) (Fig. 5E ), reinforcing the idea that donor-derived vascular clusters represent functional vasculature perfused by circulation.
DISCUSSION
In the present study, using the expression of SCL-3 0 Enh cis-regulatory element in combination with transplantation and in vitro assays, we have isolated and characterized a novel progenitor population endowed with multiorgan long-term reconstituting endothelial (LTR-EC) potential from the E12 FL. Our previous studies have provided a comprehensive characterization of the hemato/vascular SCL-3 0 Enh, establishing its activity pattern in a range of progenitor and mature cell types [39, 41, 69, 70] [79] [80] [81] , increased migratory responses to chemotactic signals [82] , enhanced trans-endothelial migratory capacity, [83] and distinctive expression of Mac-1 [43, 84] and VEcad [47, 54] , molecules potentially involved in their recruitment to sites of neovascularization [85, 86] . Also, FL HSCs present a platelet/myeloid lineage-skewed repopulation potential [81, 87] , which can be a potentially relevant issue considering that myeloid cells constitute one of the main pro-angiogenic hematopoietic cells recruited to sites of vascular damage [22, 88, 89] , also involved in vessel anastomosis and remodeling during embryogenesis [90, 91] . Potential cooperative pro-angiogenic action of FL-derived myeloid cells may be exerted at short-term post-transplantation, as no donor derived SCL-PLAP 1 F4/80 1 myeloid cells were observed in liver section from long-term chimeras [35] (and data not shown). Further SCL-PLAP 1 VE-cad 1 CD45 2 cells cotransplantation assays with different FL myeloid/macrophage cell subsets [91, 92] should clarify this issue.
Intrinsic characteristics of EC/EPC populations that are related to their origin and developmental stage may also account for vascular engraftment potential. Changes in liver endothelial cells during development have been associated with modulating marker expression, including Lyve1 [58, 93] . The microvascular sinusoids start forming in the FL around E9 of development and can be identified by the histological expression of Flk1, Stab1, and CD31. However, the hyaluronan-receptor Lyve1 emerges in part of the sinusoids at E10, when sinusoidal lumen formation becomes more evident [58, 64, 93] . In accordance with this data, we observed that while most E10 FL SCL-PLAP 
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features, including engulfment capability and emergence of fenestrations, have also been associated to liver sinusoidal EC phenotypic changes along development [58, 93] . However, the implications of Lyve1 expression on the function of EC/EPC remained speculative. In addition, Lyve1 knock-out mice have no apparent liver phenotype [94, 95] . Differences between midgestation FL and adult liver EC/ EPCs may account for the absence of reconstitution potential from the adult LSEC-NPC cell fraction when transplanted into newborn mice. Adult liver-derived LSECs and sinusoidal progenitor cells have been effectively used for correction of bleeding disorders [32] and promotion of liver regeneration [27, 29] in rodents and might thus be considered for therapeutic applications. However, vascular integration of transplanted adult LSECs requires extreme and highly damaging preconditioning regime of the host, including hepatectomy, treatment with toxic agents for ECs, irradiation or severe genetic predisposition [26, 28, 76] , conditions that do not seem to be induced by the here applied busulfan treatment [96] . FL Lyve1 1 cells present features of immaturity, including the expression of progenitor associated marker CD34 and the lack of fenestrations [58] . Interestingly, previous reports involving primary postnatal endothelial progenitors from the vascular wall have correlated the incremented in vitro OP9-EC colony formation potential with an EC immature status [24] . We also showed that FL Lyve1 1 cells presented a higher EC cord/colony formation potential compared to adult counterpart cells, supporting the idea that FL cells are functionally more immature than adult LSEC cells. Moreover, comparative PCR-based quantification of repopulation of monocrotaline treated mouse liver endothelium indicates that, related to adult liver, donor FL CD31
1 ECs presented a more robust repopulation potential [97] . This result suggests that FL Lyve1 1 cells, likely responsible for liver vascular engraftment, possess characteristics of immature progenitor cells compared to their adult counterparts. Although the use of primary or in vitro generated EC/EPC with FL-EC characteristics could be regarded as a more efficient alternative to the use of adult LSEC, it is important to take into consideration that FL SCL-PLAP 1 VE-cad 1 CD45 2 population reported here or human FL CD31 1 population reported by others [97] , might include hematopoietic cooperative cells modulating the effective vascular integration of endothelial lineage committed EC/EPCs. As promoting vasculogenesis is an essential step for fostering liver regeneration and repair [29, 98] or correcting coagulation defects [32, 76] , it will be important to further investigate the characteristics and mechanisms that confer FL SCL-PLAP 
CD45
2 cells may provide a more robust vascular engraftment than BM-derived [35] or adult liver-derived EC/EPC populations, constituting a novel and highly promising source of cells to study vascular reconstitution and repair in neonatal preclinical models and also might help guide the derivation of long term reconstituting vascular progenitors from pluripotent stem cells.
